Coronavirus Disease 2019 (COVID-19) Vaccines Report: Contract Development and Manufacturing Landscape - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 8, 2021--
The “Coronavirus Disease 2019 (COVID-19) Vaccines - Contract Development and Manufacturing Landscape” report has been added to ResearchAndMarkets.com’s offering.
This expert trend report is a comprehensive look at the contract manufacturing landscape surrounding COVID-19 Vaccine in 2020, including analysis of pipeline drugs, clinical trials, CMO activity, Contract Manufacturing Service Agreements, and funding for manufacturing of COVID-19 Vaccines. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.
- This report gives an important expert quantitative analysis on the COVID-19 contract vaccine manufacturing industry.
Reasons to Buy
- What are the pipeline COVID-19 prophylactic vaccines by developer type?
- What are the top pipeline COVID-19 prophylactic vaccines analyst consensus sales forecast?
- What is the distribution of COVID-19 prophylactic vaccines clinical trials?
- What and Where are CMOs vaccine manufacturing facilities?
- What are the COVID-19 vaccine contract manufacturing service agreements by Molecule Type?
- What are the COVID-19 vaccine contract manufacturing service agreements by Service?
- What are the COVID-19 vaccine contract manufacturing service agreements by CMO?
- What are the COVID-19 vaccine contract manufacturing service agreements by Sponsor?
Key Topics Covered:
1 Executive Summary
3 Technology Briefing
3.1 What is COVID-19?
3.2 COVID-19 Pipeline Vaccine Types and Technology
5 Industry Analysis
5.1 COVID-19 Pipeline Vaccines
5.2 COVID-19 Vaccine Projected Sales
5.3 Contract Manufacturing Capabilities for Vaccines
5.4 COVID-19 Vaccine Contract Service Agreements
5.5 Investors in COVID-19 Vaccine Manufacturing
5.5.2 Pharma Companies
6 Value Chain
Companies Mentioned (Partial List)
- 3T Biosciences Inc.
- 7 Hills Pharma LLC
- Abnova Corp.
- AbVision Inc.
- Acibadem University
- Adaptive Phage Therapeutics Inc.
- Adimmune Corp.
- Advanced BioScience Laboratories Inc.
- Advent Srl
- Aegis Life Inc.
- AGC Biologics Inc.
For more information about this report visit https://www.researchandmarkets.com/r/je7mpw
View source version on businesswire.com:https://www.businesswire.com/news/home/20210108005313/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 01/08/2021 08:45 AM/DISC: 01/08/2021 08:45 AM